Atherosclerosis in Rheumatology: Old and New Insight

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F20%3A10420107" target="_blank" >RIV/00216208:11110/20:10420107 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00023728:_____/20:N0000010

Výsledek na webu

<a href="https://doi.org/10.5772/intechopen.88605" target="_blank" >https://doi.org/10.5772/intechopen.88605</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5772/intechopen.88605" target="_blank" >10.5772/intechopen.88605</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Atherosclerosis in Rheumatology: Old and New Insight

Popis výsledku v původním jazyce

Cardiovascular diseases are the leading cause of morbidity and mortality in general population worldwide. There is an increasing significance of cardiovascular risk in the field of rheumatology, and accordingly, the evidence on the relation between immune system disorders and atherosclerosis has been substantially growing especially in last decades. Since novel immune and metabolic factors are considered to participate in pathogenesis of atherosclerosis and increased cardiovascular risk in rheumatic patients, they are getting to the forefront of the research. Since novel therapeutic approaches have improved survival of rheumatic patients, and decreased morbidity caused by rheumatic disease activity and damage, the significance of other comorbidities leading to premature mortality has arisen. Nevertheless, appropriate recommendations for the management of cardiovascular risk are still lacking. Recently, European League Against Rheumatism (EULAR) recommendations for management of the cardiovascular risk and comorbidities in patients with inflammatory arthropathies have been published. However, the cardiovascular management of these patients is still suboptimal. In addition, the situation in other orphan diseases such as idiopathic inflammatory myopathies, systemic sclerosis and others is even more uncertain and strongly requires further research. This chapter provides an overview of epidemiology, pathogenesis, clinical manifestations, screening and management of atherosclerosis in patients with rheumatic diseases.

Název v anglickém jazyce

Atherosclerosis in Rheumatology: Old and New Insight

Popis výsledku anglicky

Cardiovascular diseases are the leading cause of morbidity and mortality in general population worldwide. There is an increasing significance of cardiovascular risk in the field of rheumatology, and accordingly, the evidence on the relation between immune system disorders and atherosclerosis has been substantially growing especially in last decades. Since novel immune and metabolic factors are considered to participate in pathogenesis of atherosclerosis and increased cardiovascular risk in rheumatic patients, they are getting to the forefront of the research. Since novel therapeutic approaches have improved survival of rheumatic patients, and decreased morbidity caused by rheumatic disease activity and damage, the significance of other comorbidities leading to premature mortality has arisen. Nevertheless, appropriate recommendations for the management of cardiovascular risk are still lacking. Recently, European League Against Rheumatism (EULAR) recommendations for management of the cardiovascular risk and comorbidities in patients with inflammatory arthropathies have been published. However, the cardiovascular management of these patients is still suboptimal. In addition, the situation in other orphan diseases such as idiopathic inflammatory myopathies, systemic sclerosis and others is even more uncertain and strongly requires further research. This chapter provides an overview of epidemiology, pathogenesis, clinical manifestations, screening and management of atherosclerosis in patients with rheumatic diseases.

Druh

C - Kapitola v odborné knize

CEP obor

—

OECD FORD obor

30226 - Rheumatology

Projekt

<a href="/cs/project/NV18-01-00161" target="_blank" >NV18-01-00161: Ateroskleróza a kardiovaskulární riziko u vybraných revmatických onemocnění</a><br>

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

Atherosclerosis, Arteriosclerosis and Arteriolosclerosis

ISBN

978-1-83880-303-2

Počet stran výsledku

24

Strana od-do

29-52

Počet stran knihy

71

Název nakladatele

IntechOpen

Místo vydání

London

Kód UT WoS kapitoly

—